Montagner, Diego and Qi Yap, Siew and Han Ang, Wee (2013) A Fluorescent Probe for Investigating the Activation of Anticancer Platinum(IV) Prodrugs Based on the Cisplatin Scaffold. Angewandte Chemie International Edition, 125 (45). pp. 12001-12005. ISSN 1521-3773

Preview

Download (783kB) | Preview

Abstract

Following the discovery of its potent antitumoral activity in 1965, the inorganic drug cisplatin has become one of the most important anticancer agents in clinical use.1 It exhibits exceptional activity against germ-cell testicular cancer, for which it is the first-line therapeutic option.2 Its success led to the development of second-generation drugs, namely carboplatin and oxaliplatin, both of which are also based on the cis-diam(m)ineplatinum(II) pharmacophore. Together, these FDA-approved PtII drugs constitute some of the most widely used chemotherapeutic agents (Figure 1).3 Yet, despite their clinical success, the use of PtII drugs is limited by their high toxicity, severe side-effects, and incidences of drug resistance.4 To address some of these limitations, researchers have developed stable PtIV carboxylate complexes as anticancer prodrugs that can be activated by intracellular reduction to release their latent cytotoxic activity.5 This versatile strategy has been used to develop PtIV prodrug complexes with highly tuned properties,6 which are capable of targeting,7 as well as delivering novel modes of action.8 The most prominent example is satraplatin, which is currently undergoing Phase III clinical trials against hormone-refractory prostate cancer (Figure 1).9 Although there is much interest in understanding and exploiting this prodrug strategy as a springboard towards the next generation of Pt drugs, tools capable of directly visualizing the uptake and accumulation of these clinically important compounds are lacking. Herein, we describe a fluorescent probe that was custom-built for the detection of PtII drugs such as cisplatin. Using confocal microscopy, we could determine the localization of the PtIV prodrugs in cancer cells in vitro after cell entry and intracellular reduction.

Item Type:	Article
Keywords:	Fluorescent Probe; Activation; Anticancer Platinum(IV) Prodrugs; Cisplatin Scaffold;
Academic Unit:	Faculty of Science and Engineering > Chemistry
Item ID:	7065
Identification Number:	https://doi.org/10.1002/ange.201305734
Depositing User:	Diego Montagner
Date Deposited:	01 Apr 2016 13:57
Journal or Publication Title:	Angewandte Chemie International Edition
Publisher:	Wiley
Refereed:	Yes
URI:	Publisher
Use Licence:	This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

Repository Staff Only(login required)

Item control page

Downloads

Origin of downloads